Your browser doesn't support javascript.
loading
Comparison of Expected Versus Actual Cost Consequence Of Reimbursed Drugs in the Netherlands Between 2009 and 2013.
Chatterjee, A; Tempelaar, S; Verheggen, B.
Affiliation
  • Chatterjee A; Pharmerit International, York, UK.
  • Tempelaar S; Pharmerit International, York, UK.
  • Verheggen B; Pharmerit International, Rotterdam, The Netherlands.
Value Health ; 17(7): A426, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27201098
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Reino Unido